Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Decreased Target to $24 on, Dec 28th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-24-on-dec-28th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $88 to $24 on, Dec 28th, 2021.

Raghuram has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021

Publication Contributing Sources